{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T14:50:07Z","timestamp":1670770207967},"reference-count":15,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.2337\/dbi18-0051","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T01:15:37Z","timestamp":1550711737000},"page":"476-478","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the Brain to Cure Type 2 Diabetes"],"prefix":"10.2337","volume":"68","author":[{"given":"Bernard","family":"Thorens","sequence":"first","affiliation":[{"name":"Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"2022031303402084100_B1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/db18-0498","article-title":"Peripheral mechanisms mediating the sustained antidiabetic action of FGF1 in the brain","volume":"68","author":"Scarlett","year":"2019","journal-title":"Diabetes"},{"key":"2022031303402084100_B2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm.4101","article-title":"Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents","volume":"22","author":"Scarlett","year":"2016","journal-title":"Nat Med"},{"key":"2022031303402084100_B3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"2022031303402084100_B4","doi-asserted-by":"crossref","first-page":"e33603","DOI":"10.1371\/journal.pone.0033603","article-title":"Characterization of a FGF19 variant with altered receptor specificity revealed a central role for FGFR1c in the regulation of glucose metabolism","volume":"7","author":"Ge","year":"2012","journal-title":"PLoS One"},{"key":"2022031303402084100_B5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molmet.2013.10.002","article-title":"Central action of FGF19 reduces hypothalamic AGRP\/NPY neuron activity and improves glucose metabolism","volume":"3","author":"Marcelin","year":"2013","journal-title":"Mol Metab"},{"key":"2022031303402084100_B6","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1172\/JCI70710","article-title":"FGF19 action in the brain induces insulin-independent glucose lowering","volume":"123","author":"Morton","year":"2013","journal-title":"J Clin Invest"},{"key":"2022031303402084100_B7","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1038\/ncomms7980","article-title":"FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis","volume":"6","author":"Perry","year":"2015","journal-title":"Nat Commun"},{"key":"2022031303402084100_B8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/en.2012-1891","article-title":"Fibroblast growth factor-19 action in the brain reduces food intake and body weight and improves glucose tolerance in male rats","volume":"154","author":"Ryan","year":"2013","journal-title":"Endocrinology"},{"key":"2022031303402084100_B9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1096\/fj.00-0590","article-title":"Diseases of liporegulation: new perspective on obesity and related disorders","volume":"15","author":"Unger","year":"2001","journal-title":"FASEB J"},{"key":"2022031303402084100_B10","doi-asserted-by":"crossref","first-page":"E1730","DOI":"10.1152\/ajpendo.00572.2007","article-title":"Dynamics of insulin sensitivity, \u03b2-cell function, and \u03b2-cell mass during the development of diabetes in fa\/fa rats","volume":"293","author":"Topp","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031303402084100_B11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/jne.12191","article-title":"Tanycytes: a gateway to the metabolic hypothalamus","volume":"26","author":"Langlet","year":"2014","journal-title":"J Neuroendocrinol"},{"key":"2022031303402084100_B12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cmet.2013.03.004","article-title":"Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting","volume":"17","author":"Langlet","year":"2013","journal-title":"Cell Metab"},{"key":"2022031303402084100_B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2006.12.002","article-title":"A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2","volume":"5","author":"Coppola","year":"2007","journal-title":"Cell Metab"},{"key":"2022031303402084100_B14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/gast.1996.v110.pm8608899","article-title":"Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation","volume":"110","author":"Kiba","year":"1996","journal-title":"Gastroenterology"},{"key":"2022031303402084100_B15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature13540","article-title":"Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer","volume":"513","author":"Suh","year":"2014","journal-title":"Nature"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/68\/3\/476\/427916\/dbi180051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/68\/3\/476\/427916\/dbi180051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:37:28Z","timestamp":1667407048000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/68\/3\/476\/39811\/Targeting-the-Brain-to-Cure-Type-2-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":15,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,13]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dbi18-0051","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]}}}